Show Summary Details
Page of

SETBP1 and Schinzel-Giedion Syndrome 

SETBP1 and Schinzel-Giedion Syndrome
SETBP1 and Schinzel-Giedion Syndrome

Kenichi Yoshida

, Bregje W. M. Van Bon

, and Seishi Ogawa

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 February 2021

Schinzel-Giedion syndrome (SGS) is a rare multiple congenital malformation complex characterized by distinctive facial features, multiple congenital anomalies (including skeletal, genitourinary and cardiac malformations), severe intellectual disability and a high prevalence of tumors, especially neuroepithelial neoplasia. Most affected individuals die during infancy mainly because of respiratory failure. As for the causative gene of SGS, de novo germline mutations have been identified in the SETBP1 gene, which has recently been reported to be somatically mutated in a wide variety of myeloid malignancies. Affecting the identical hot spot amino acids, these mutations are thought to result in gain-of-function, being responsible for the pathogenesis of SGS and myeloid malignancies.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.